Ensayos clínicos
| Ensayo | Promotor | Enfermedad | |||
|
Phase I Clinical Study of Dose-escalation Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of Recombinant Anti-FGFR Human-mouse Chimeric Monoclonal Antibody Injection BK011 in Patients with Advanced Malignant Solid Tumors
Inicio: 18/5/2022 Reclutamiento: Final: Estado: En proceso |
Zhejiang Newind Biotechnology Co. | Esophageal Neoplasms; Stomach Neoplasms | ||
|
|
Phase I/II Clinical Study of Mitoxantrone Hydrochloride Liposomes in Combination With Gemcitabine, Dexamethasone, and Cisplatin in Relapsed/Refractory Peripheral T-cell Lymphoma
Inicio: 1/5/2022 Reclutamiento: Final: Estado: En proceso |
Peking Union Medical College Hospital, CAMS CSPC Pharmaceutical Group Co./CSPC Ouyi Pharmaceutical Co. | Lymphoma; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral | ||
|
|
Single arm and single center clinical study on safety, tolerance and efficacy of GC101 injection in patients with type 1 spinal muscular atrophy
Inicio: 16/2/2022 Reclutamiento: Final: Estado: En proceso |
(Other Hospital/Academic/Medical Center) GeneCradle | Spinal Muscular Atrophy | ||
|
|
Clinical Study on the Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer
Inicio: 2/4/2021 Reclutamiento: Final: Estado: En proceso |
Shanghai Biomed-Union Biotechnology Co. | Pancreatic Neoplasms | ||
|
|
Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for Injection in the Treatment of Relapsed or Relapsed and Refractory Multiple Myeloma
Inicio: 26/6/2022 Reclutamiento: Final: Estado: En proceso |
CASI Pharmaceuticals {EntreMed} (Other Hospital/Academic/Medical Center) | Multiple Myeloma; Neoplasms, Plasma Cell | ||
|
|
A Phase I study of ZS801 injection, an rAAV gene therapy drug of Sichuan Zhishan Weixin Biotechnology Co., Ltd., in hemophilia B subjects.
Inicio: 1/1/1900 Reclutamiento: Final: Estado: En proceso |
Sichuan Zhishan Weixin Biotechnology Co. | Blood Coagulation Disorders; Hemophilia B; Hemostatic Disorders | ||
|
|
A Phase I Clinical Study of CD70-targeting CAR-T Therapy in the Treatment of Advanced/Metastatic Renal Cell Carcinoma
Inicio: 31/12/2021 Reclutamiento: Final: Estado: En proceso |
Chongqing Precision Biotech Co. | Carcinoma; Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasm Metastasis; Wilms Tumor | ||
|
|
This is a Phase I Clinical Study to Evaluate the Safety and Efficacy of CAR-T Infusion Preparation in the Treatment of CD19-positive Relapsed/Refractory Non-Hodgkin Lymphoma
Inicio: 6/9/2021 Reclutamiento: Final: Estado: En proceso |
Chongqing Precision Biotech Co. | Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin | ||
|
|
An Open, Single-armed, Phase I Study to Evaluate the Safety and Efficacy Using Autologous TIL in Patients With Advanced Malignant Solid Tumors
Inicio: 14/6/2022 Reclutamiento: Final: Estado: En proceso |
Shanghai Gencells Therapeutics Co. | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug-Related Side Effects and Adverse Reactions; Head and Neck Neoplasms; Melanoma; Neoplasms; Uterine Cervical Neoplasms | ||
|
|
A Phase I Clinical Study of Anti-CEA CAR-T Therapy in the Treatment of CEA-positive Advanced Malignant Solid Tumors
Inicio: 10/9/2021 Reclutamiento: Final: Estado: En proceso |
Chongqing Precision Biotech Co. | Colorectal Neoplasms; Esophageal Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms; Recurrence; Stomach Neoplasms | ||